肝素在血栓栓塞治疗中的应用指征及技术 - Suppr

Suppr

超能文献

Indications and techniques for the use of heparin in the treatment of thromboembolism.

作者信息

Deykin D

出版信息

World J Surg. 1978 Jan;2(1):39-43. doi: 10.1007/BF01574457.

DOI:10.1007/BF01574457

PMID:351981

Abstract

摘要

相似文献

Indications and techniques for the use of heparin in the treatment of thromboembolism.肝素在血栓栓塞治疗中的应用指征及技术

World J Surg. 1978 Jan;2(1):39-43. doi: 10.1007/BF01574457.

Classical anticoagulant therapy for venous thromboembolism.

Prog Cardiovasc Dis. 1994 Sep-Oct;37(2):59-70. doi: 10.1016/s0033-0620(05)80042-8.

[Low molecular weight heparin--1998 status].[低分子量肝素——1998年现状]

Praxis (Bern 1994). 1999 Apr 29;88(18):802-7.

[Use of continuous flow heparin in resuscitation].[持续输注肝素在复苏中的应用]

Anesth Analg (Paris). 1977 Nov-Dec;34(6):1239-41.

Drug trials that have influenced our practice in the treatment of venous thromboembolism.影响我们静脉血栓栓塞治疗实践的药物试验。

Thromb Haemost. 1997 Jul;78(1):553-7.

[Double-blind cross-over controlled study on a calcium-heparin preparation].

Clin Ter. 1985 Jun 30;113(6):473-7.

[Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].[普通肝素或低分子量肝素用于治疗静脉血栓栓塞性疾病？]

Med Clin (Barc). 1998 Nov 28;111(18):697-9.

[Orthopedic and traumatologic clinical experimentation with a heparin preparation].[一种肝素制剂的骨科与创伤临床实验]

Minerva Ortop. 1969 Apr;20(4):149-52.

Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.肝素和低分子量肝素治疗静脉血栓栓塞症。抗凝监测的黄昏。

Int Angiol. 1998 Dec;17(4):213-24.

The summary retrospective assessment of anticoagulants in myocardial infarction.心肌梗死中抗凝剂的总结性回顾评估

Am J Med Sci. 1966 Mar;251(3):249-54. doi: 10.1097/00000441-196603000-00001.

本文引用的文献

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.抗凝药物治疗肺栓塞的对照试验。

Lancet. 1960 Jun 18;1(7138):1309-12. doi: 10.1016/s0140-6736(60)92299-6.

Warfarin therapy. 1.华法林治疗。1.

N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307.

Heparin action.肝素的作用。

Circulation. 1974 Apr;49(4):603-5. doi: 10.1161/01.cir.49.4.603.

The purification and mechanism of action of human antithrombin-heparin cofactor.人抗凝血酶-肝素辅因子的纯化及其作用机制

J Biol Chem. 1973 Sep 25;248(18):6490-505.

Heparin in the treatment of pulmonary thromboembolism.肝素在肺血栓栓塞症治疗中的应用

Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):519-27.

Management of heparin therapy: Controlled prospective trial.肝素治疗的管理：对照前瞻性试验。

N Engl J Med. 1975 May 15;292(20):1046-50. doi: 10.1056/NEJM197505152922002.

Randomized prospective trial of continuous vs intermittent heparin therapy.

JAMA. 1976 Sep 20;236(12):1365-7.

Heparin-induced immune thrombocytopenia.肝素诱导的免疫性血小板减少症。

N Engl J Med. 1976 Jul 29;295(5):237-41. doi: 10.1056/NEJM197607292950501.

Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients.肝素给药期间出现的血小板减少症。对52例患者的前瞻性研究。

Ann Intern Med. 1976 Aug;85(2):155-60. doi: 10.7326/0003-4819-85-2-155.

Haemorrhagic complications of heparin therapy.肝素治疗的出血并发症。

Lancet. 1977 May 28;1(8022):1133-5. doi: 10.1016/s0140-6736(77)92388-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验